GEN Exclusives

More »

GEN News Highlights

More »
Dec 4, 2006

Neurobiological Technologies and Nordmark Complete GMP Snake Facility

  • Neurobiological Technologies (NTI) completed construction of a snake facility in Moorrege, Germany, near Hamburg. The facility, owned and operated by NTI’s partner, Nordmark Arzneimittel, houses snakes that will provide the venom used to produce Viprinex, which is being studied by NTI as a potential treatment for acute ischemic stroke.

    “A home was needed for the snakes used to produce Viprinex, and we decided with Nordmark that it was necessary to create one of the world’s few GMP facilities for reptiles,” says Paul E. Freiman, CEO of NTI. “This facility currently houses 100 snakes and is expected to eventually be home to 1,500 vipers.”

    According to Freiman, the two companies shared the expense of this facility at a cost of EUR4.5 million.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?